ZHAOKE OPHTH-B News

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - APPROVAL OF INVESTIGATIONAL NEW DRUG APPLICATION FOR PHASE III CLINICAL TRIAL OF CYCLOSPORINE A (CsA) OPHTHALMIC GEL BY NMPA AND COMPLETION OF NVK002 PHASE III CHINA-CHAMP LAST PATIENT LAST VISIT IN CHINA

Aug 11 19:54 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 July 2024

Jul 31 23:10 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 June 2024

Jul 2 02:51 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024

Jun 3 05:51 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024

May 2 07:51 ET

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO REGISTERED SHAREHOLDERS AND REPLY FORM

Apr 26 10:46 ET

ZHAOKE OPHTH-B: NOTIFICATION LETTER TO NON-REGISTERED SHAREHOLDERS AND REPLY FORM

Apr 26 10:43 ET

ZHAOKE OPHTH-B: FORM OF PROXY FOR USE AT THE ANNUAL GENERAL MEETING TO BE HELD ON FRIDAY, MAY 17, 2024

Apr 26 10:38 ET

ZHAOKE OPHTH-B: Environmental, Social and Governance Report 2023

Apr 26 10:26 ET

ZHAOKE OPHTH-B: LIST OF DIRECTORS AND THEIR ROLE AND FUNCTION

Apr 8 06:16 ET

ZHAOKE OPHTH-B: RESIGNATION OF NON-EXECUTIVE DIRECTOR

Apr 8 06:12 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 March 2024

Apr 2 06:06 ET

ZHAOKE OPHTH-B: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 21 05:51 ET

ZHAOKE OPHTH-B: Letter to Registered Shareholders - Arrangement for Electronic Dissemination of Corporate Communications and Reply Form

Mar 21 05:50 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 29 February 2024

Mar 1 00:46 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 January 2024

Feb 1 04:03 ET

ZHAOKE OPHTH-B: VOLUNTARY ANNOUNCEMENT - ENTERING INTO DISTRIBUTION AGREEMENT WITH KWANGDONG PHARMACEUTICAL TO COMMERCIALIZE BRIMOCHOL PF IN THE REPUBLIC OF KOREA

Jan 28 19:28 ET

ZHAOKE OPHTH-B: Voluntary Announcement - INVESTIGATIONAL NEW DRUG APPLICATIONS FOR CLINICAL TRIAL OF BRIMOCHOL PF AND CARBACHOL PF FOR THE TREATMENT OF PRESBYOPIA APPROVED BY NMPA

Jan 24 03:31 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

Jan 3 22:04 ET

ZHAOKE OPHTH-B: Monthly Return of Equity Issuer on Movements in Securities for the Month ended 30 November 2023

Dec 1, 2023 02:21 ET